Eligible for Vaccination Against Influenza Completed Phase 1 / 2 Trials for Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen (DB11037)

IndicationStatusPhase
DBCOND0049621 (Eligible for Vaccination Against Influenza)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01248208FluMist in Egg Allergic PatientsPrevention